3/27/2013 Kentucky Joins Georgia as the Only States in the Country to Offer Motorists a Lung Cancer Awareness Specialty License Plate!Read NowThe Joan Gaeta Lung Cancer Fund congratulates Big Daddy's Race for Time and everyone in Kentucky responsible for making this a reality in their state! The following was originally published by Alan Lytle at WUKY.org on 3/27/13. LEXINGTON, Ky. - Kentucky motorists will soon be able to demonstrate support for lung cancer research and education by buying a specialty license plate. A new “Fighting Lung Cancer” tag has been approved for pre-sale and should be available by early 2014. Lung cancer is the leading cause of cancer deaths both in Kentucky and the nation, according to Renae Feistritzer Ellis, president of the non-profit group, Big Daddy’s Race for Time. “It surpasses prostate cancer, breast cancer…I mean it’s a huge killer and it’s kind of a silent killer because there’s just not a lot of information out there about it.” Feistritzer Elllis created Big Daddy’s Race For Time, to honor her late father. “Upon his death we created the foundation and all of our money goes right back into Kentucky. We’ve worked closely with the Kentucky Research program with the Markey Cancer Center. That’s where our funds have gone to the last five years. We meet with some doctors and we ask what research efforts they’re doing and we actually pick which research, clinical trials that we want our money go towards.” 900 of the license plates will need to be pre-ordered at $25 each before the design can be sent to production. You can pre-order yours at http://www.bigdaddysrace.org/licenseplate/
0 Comments
3/26/2013 The Lung Cancer Living Room - Personalizing Your Care - Dr. David Gandara - Feb. 19, 2013Read NowIn his second visit to the Lung Cancer Living Room, Dr. David Gandara of UC Davis Comprehensive Cancer Center, discusses how your cancer is unique and that your approach to treating it should be too. He talks about discovering your 'molecular fingerprint' and how that information will help guide you through your unique cancer 'journey'. He also talks about some of the latest findings regarding "Tumor Darwinism"- how your cancer's molecular signature can evolve over time, as well as some of the latest research funded by the Bonnie J. Addario Lung Cancer Foundation using mouse models to test new forms of treatment. He closes with a discussion of the importance of getting involved in clinical trials. The bottom line he says is that empowered patients live longer. It is a visit filled with lots of useful detailed information, and a clear message of hope and progress.
Learn more about The Lung Cancer Living Room here. The following was originally published at dailylocal.com on Monday, March 11th, 2013 by Dr. Alicia McKelvey. Dr. McKelvey is a thoracic surgeon on staff at Paoli Hospital in Chester County, PA. Lung cancer is the leading cause of cancer death in the US. In fact, more people die of lung cancer than of colon, breast and prostate cancers combined. Screening for colon, breast and prostate cancer have played a significant role in reducing the number of deaths due to these diseases. Until recently, however, no screening test for lung cancer has proven effective in detecting the disease at an early, more treatable stage. In August 2011, the National Lung Screening Trial, sponsored by the National Cancer Institute, released findings from the first scientific study of an effective screening technique using advanced imaging technology called the low dose helical CT scan (LDHCT) that significantly reduces death due to lung cancer in high risk individuals. This study demonstrated 20 percent fewer lung cancer deaths in those who underwent screening with LDHCT as compared with those who were screened with standard chest x-rays. High risk individuals are those who are 55 to 74 years old and who have a 30 or more pack year smoking history and former smokers who quit within the last 15 years. Pack years is a term used to categorize smoking history and is calculated by the number of packs smoked each day times the years of smoking. Screening with the low-dose CT scan enabled the detection of lung cancer at its earliest stage when there are typically no symptoms to indicate a problem. Early stage lung cancer means the disease has not spread to other organs or to lymph nodes. Knowing the stage along with other factors, including the type of cancer and the patient’s overall health, helps doctors to recommend the best treatment. Treatment options for lung cancer include surgery, radiation, chemotherapy or any combination of these therapies. The typical course for early stage lung cancer is surgery to remove the diseased tissue. If concerned about lung cancer, contact a physician to discuss ways to reduce the risk and whether screening with a LDHCT is beneficial. 3/20/2013 @bonniejaddario Responds to @consumerreports March Issue Cover Story #lungcancer #earlydetection #factsRead NowBonnie Addario Leading magazine downplays value of lung cancer screenings, to the detriment of advances in early detection research. SAN CARLOS, Calif., March 20, 2013 /PRNewswire -- The following statement was issued by Bonnie J. Addario regarding the March cover article in Consumer Reports: The cancer tests you need--and those you don't: "I am appalled by the March 2013 Consumer Reports cover story (The cancer tests you need--and those you don't), because of the misleading and misguided message it sends to people who really need life-saving cancer screening tests, and how it discredits the value and importance of proper early detention cancer screening tests. "The article's irresponsible reporting is best summed up in this statement on page 31: 'But most people shouldn't waste their time on screenings for bladder, lung, oral, ovarian, prostate, pancreatic, skin or testicular cancers.' "Consumer Reports is one of the most trusted publications in America. Anyone, whether they know they are low or high risk, will read that statement and walk away believing early detection cancer screening tests are unnecessary. The six-page article mentions only twice that its ratings apply only to asymptomatic, low-risk population. "Shame on Consumer Reports. We are talking about people's lives here. "I myself am a lung cancer survivor. For more than a year I was misdiagnosed and not given an early detection screening test, even though I was in a high-risk category. When I was finally diagnosed I was stage 3B. Unlike so many others, I beat the odds. But my odds would have been better with an early detection cancer screening test. I founded the Bonnie J. Addario Lung Cancer Foundation seven years ago to advocate and raise money for better research, education, early detection and treatment. Because something must be done. The stats are staggering.
"Cancer screening and treatment are certainly at a crossroads, as the article states. This is made clear as well by recent legislation to direct more tobacco settlement money to early lung cancer detection programs. But the article's irresponsible representation of the value of screening tests, I fear, might damage the progress my lung cancer foundation has made over the past seven years - just as we are making great strides. "People cannot readily see symptoms of lung cancer. Symptoms are deep in the lungs, unlike breast cancer, where lumps can be felt and are visible. When you are diagnosed with lung cancer it is often at stage four, when it's too late. "The Consumer Reports article makes only one responsible and thoughtful statement: 'Weighing the risks and benefits of cancer screening is best done in the context of a patient-doctor relationship.' "Consumer Reports should stay out of the health care advice business, and stick to writing about toasters and washing machines. I wouldn't approach my doctor about whether I should buy a Honda or a Ford. And likewise, people should not consult Consumer Reports to help them decide whether or not to have a potentially life-saving cancer screening test." About the Bonnie J. Addario Lung Cancer Foundation The Bonnie J. Addario Lung Cancer Foundation is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation works with a diverse group of physicians, organizations, industry partners, individuals, survivors, and their families to identify solutions and make timely and meaningful change. BJALCF was established on March 6, 2006 as a 501c(3) non-profit organization and has raised more than $9 million for lung cancer research. |
Details
|